Bill > HB1268

This bill requires health insurance providers in Maryland to cover long-term antibiotic treatment for Lyme disease and related tick-borne illnesses under specific conditions. The bill defines key terms, including "long-term antibiotic treatment" as the administration of antibiotics for more than 4 weeks, and "Lyme disease" broadly to encompass various clinical diagnoses and manifestations of the illness. When a licensed physician orders long-term antibiotic treatment for therapeutic purposes, insurance companies must provide coverage for the full length of treatment as prescribed and cannot impose quantitative limitations on the treatment. Additionally, insurers cannot deny coverage solely because the treatment might be considered experimental or unproven. The bill applies to health insurers, nonprofit health service plans, and health maintenance organizations operating in Maryland, and will take effect on January 1, 2026, applying to all insurance policies, contracts, and health benefit plans issued or renewed on or after that date. The legislation aims to provide more comprehensive medical care and insurance coverage for patients suffering from Lyme disease and related tick-borne illnesses.

Health and Social Services

https://mgaleg.maryland.gov/mgawebsite/Legislation/Details/HB1268?ys=2025RS